Dai, Chang http://orcid.org/0000-0001-7971-883X
Waduge, Prabuddha http://orcid.org/0000-0001-5806-9578
Ji, Liyang http://orcid.org/0000-0002-2844-7942
Huang, Chengchi
He, Ye
Tian, Hong
Zuniga-Sanchez, Elizabeth
Bhatt, Amit
Pang, Iok-Hou
Su, Guanfang
Webster, Keith A.
Funding for this research was provided by:
National Eye Institute (R01EY027749, R24EY028764, R24EY028764-01A1S1, R43EY031238, R43EY031643, R41EY027665)
American Diabetes Association (1-18-IBS-172)
Article History
Received: 18 August 2021
Revised: 29 November 2021
Accepted: 17 December 2021
First Online: 10 January 2022
Declarations
:
: HT and WL are shareholders of Everglades Biopharma, LLC and LigandomicsRx, LLC. The remaining authors declare no competing financial interests.
: All animal studies were approved by the Institutional Animal Care and Use Committee at University of Miami and Baylor College of Medicine.
: Not applicable.
: Not applicable.